Direct-to-Consumer Hearing Devices for Adults With Hearing Loss: Definitions, Summary of Literature, and Analysis of Risks and Benefits

2018 ◽  
Vol 3 (7) ◽  
pp. 5-11 ◽  
Author(s):  
Vinaya Manchaiah
2017 ◽  
Vol Volume 12 ◽  
pp. 859-871 ◽  
Author(s):  
Vinaya Manchaiah ◽  
Brian Taylor ◽  
Ashley Dockens ◽  
Nicole Tran ◽  
Kayla Lane ◽  
...  

2020 ◽  
Vol 48 (12) ◽  
pp. 030006052097228
Author(s):  
Yujie Liu ◽  
Ran Ren ◽  
Shouqin Zhao

The Bonebridge and Vibrant Soundbridge systems are semi-implanted hearing devices, which have been widely applied in patients with congenital conductive hearing loss. However, comparison between these two hearing devices is rare, especially in the same patient. We report a 23-year-old man who underwent successive implantation of Vibrant Soundbridge and Bonebridge devices in the same ear because of dysfunction of the Vibrant Soundbridge. We provide insight on the patient’s experience and compare the audiological and subjective outcomes of satisfaction.


2010 ◽  
Vol 2 (2) ◽  
pp. 139-142
Author(s):  
Mohan Kameswaran ◽  
S Raghunandhan

Abstract Hearing aids are the principal means of auditory rehabilitation for patients with moderate to severe sensori-neural hearing loss. Although technical improvements and modifications have improved the fidelity of conventional aids, hearing aids still have many limitations including the inherent self consciousness and social stigma attached to visible hearing aids. The recently introduced totally implantable hearing aids offer patients with hearing loss several potential advantages over conventional hearing aids. This article reviews the indications, surgical procedure, advantages and the current status of totally implantable hearing devices.


2020 ◽  
Vol 17 (2) ◽  
pp. 129-140
Author(s):  
Louiza Kalokairinou ◽  
Pascal Borry ◽  
Heidi C Howard

Aim: Direct-to-consumer (DTC) genetic tests (GT) have created controversy regarding their risks and benefits. In view of recent regulatory developments, this article aims to explore the attitudes of European clinical geneticists toward the oversight of DTC GT. Materials & methods: Fifteen semi-structured interviews were performed with clinical geneticists based in ten European countries. The transcripts were thematically analysized in an iterative process. Results & conclusion: Respondents strongly supported quality standards for DTC GT equal to those applied within the healthcare setting. Despite participants unanimously considering the involvement of healthcare professionals to be important, mandatory medical supervision was controversial. In this regard, promoting education and truth-in-advertising was considered as being key in maintaining a balance between protecting consumers and promoting their autonomy.


2019 ◽  
Vol 23 ◽  
pp. 233121651985830 ◽  
Author(s):  
Ibrahim Almufarrij ◽  
Kevin J. Munro ◽  
Piers Dawes ◽  
Michael A. Stone ◽  
Harvey Dillon

Direct-to-consumer (DTC) hearing devices can be purchased without consulting a hearing health professional. This project aims to compare 28 DTC devices with the most popular hearing aid supplied by the U.K. National Health Service (NHS). The comparison was based on technical performance, cosmetic acceptability, and the ability to match commonly used gain and slope targets. Electroacoustic performance was evaluated in a 2-cc coupler. Match to prescription target for both gain and slope was measured on a Knowles Electronic Manikin for Acoustic Research using a mild and also a moderate sloping hearing loss. Using an online blinded paired comparison of each DTC and the NHS reference device, 126 participants (50 were hearing aid users and 76 were nonhearing aid users) assessed the cosmetic appearance and rated their willingness-to-wear the DTC devices. The results revealed that higher purchase prices were generally associated with a better match to prescribed gain–frequency response shapes, lower distortion, wider bandwidth, better cosmetic acceptability, and higher willingness-to-wear. On every parameter measured, there were devices that performed worse than the NHS device. Most of the devices were rated lower in terms of aesthetic design than the NHS device and provided gain–frequency responses and maximum output levels that were markedly different from those prescribed for commonly encountered audiograms. Because of the absence or inflexibility of most of the devices, they have the potential to deliver poor sound quality and uncomfortably loud sounds. The challenge for manufacturers is to develop low-cost products with cosmetic appeal and appropriate electroacoustic characteristics.


2021 ◽  
Vol 42 (04) ◽  
pp. 381-388
Author(s):  
Karen A. Gordon ◽  
Blake C. Papsin ◽  
Vicky Papaioannou ◽  
Sharon L. Cushing

AbstractChildren with hearing loss require early access to sound in both ears to support their development. In this article, we describe barriers to providing bilateral hearing and developmental consequences of delays during early sensitive periods. Barriers include late identification of hearing loss in one or both ears and delayed access to intervention with hearing devices such as cochlear implants. Effects of delayed bilateral input on the auditory pathways and brain are discussed as well as behavioral effects on speech perception and other developmental outcomes including language and academics. Evidence for these effects has supported an evolution in cochlear implant candidacy in children that was started with unilateral implantation in children with profound deafness bilaterally to bilateral implantation to implantation of children with asymmetric hearing loss including children with single-side deafness. Opportunities to enhance the developmental benefits of bilateral hearing in children with hearing loss are also discussed including efforts to improve binaural/spatial hearing and consideration of concurrent vestibular deficits which are common in children with hearing loss.


Sign in / Sign up

Export Citation Format

Share Document